Proceedings of the National Academy of Sciences, Volume 123, Issue 12, March 2026. <br />Lethal toxins could become potent therapies against cancer, but their clinical utility is limited by adverse events upon systemic administration. These could be reduced if the toxins were delivered by effector cells that specifically infiltrate cancers, ...